Rating History for Verve Therapeutics (VERV) by BMO Capital
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/27/2025 | Kostas Biliouris | Downgrade | Market Perform (Outperform) |
13.50 (N/A) |
11.21 (11.13) |
-0.71% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
